12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers
Corbus Pharmaceuticals (NASDAQ:CRBP) shares increased by 20.3% to $0.4 during Monday's pre-market session. The market value of their outstanding shares is at $49.7 million.
RBC Capital Downgrades Immunogen to Sector Perform, Lowers Price Target to $6
RBC Capital analyst Kennen MacKay downgrades Immunogen (NASDAQ:IMGN) from Outperform to Sector Perform and lowers the price target from $9 to $6.
Immunogen Q4 EPS $(0.17) Down From $0.16 YoY, Sales $28.00M Beat $25.65M Estimate
Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.17) per share. This is a 206.25 percent decrease over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $28.00
Earnings Scheduled For February 25, 2022
Companies Reporting Before The Bell
• ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million.
Earnings Outlook For Immunogen
Immunogen (NASDAQ:IMGN) is set to give its latest quarterly earnings report on Friday, 2022-02-25. Here's what investors need to know before the announcement.
Analysts estimate that Immunogen will report an earnings per share (EPS) of $-1.71.
SVB Leerink Maintains Market Perform on Immunogen, Lowers Price Target to $5
SVB Leerink analyst Jonathan Chang maintains Immunogen (NASDAQ:IMGN) with a Market Perform and lowers the price target from $7 to $5.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
BMO Capital Initiates Coverage On Immunogen with Outperform Rating
BMO Capital analyst Etzer Darout initiates coverage on Immunogen (NASDAQ:IMGN) with a Outperform rating.